Vision disturbances
This medicine may cause vision disturbances.
Leaflet SULFAT DE HIDROXICLOROCHINA ACCORD 200mg film-coated tablets
- Product code:
- W67324001
- Quantity:
- 20
- Indicated for:
- autoimmune diseases; malaria
- Route of administration:
- oral
- Substance:
- hydroxychloroquine (antimalarial)
- ATC
- P01BA02 — Antiparasitic products, insecticides and repellents | Antimalarials | Aminoquinolines
Precautions:
Hydroxychloroquine is a medication used to treat malaria, as well as autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. It works by modulating the immune response and inhibiting the growth of malaria parasites.
The medication is taken orally, as directed by a doctor.
Side effects may include nausea, headache, visual disturbances, or skin rashes. In rare cases, severe adverse effects such as retinal damage or cardiac toxicity may occur.
Patients should undergo regular ophthalmologic check-ups during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
The medication is taken orally, as directed by a doctor.
Side effects may include nausea, headache, visual disturbances, or skin rashes. In rare cases, severe adverse effects such as retinal damage or cardiac toxicity may occur.
Patients should undergo regular ophthalmologic check-ups during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about SULFAT DE HIDROXICLOROCHINA ACCORD 200mg
- Substance:
- hydroxychloroquine
- Date of latest medicines list:
- 01-03-2021
- Product code:
- W67324001
- Concentration:
- 200mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 20
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.